Arrowhead Research Corp Hammered On Drug News; Deutsche Bank Lowers Price Target

By: via Benzinga
Arrowhead Research Corp (NASDAQ: ARWR) had its price target lowered from $45 to $20 by Deutsche Bank on Wednesday. The firm ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.